Effect of Maridebart Cafraglutide on the Heart's Electrical Activity
Status:
NOT_YET_RECRUITING
Trial end date:
2026-08-25
Target enrollment:
Participant gender:
Summary
The main objective of this trial is to evaluate the effect of maridebart cafraglutide subcutaneously (SC) on the placebo-corrected, change from baseline in QT interval corrected for heart rate using Fridericia's formula in participants living with overweight or obesity.